Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Infectious Wound Care Management Market Analysis & Forecasts: 2019 to 2024 - ResearchAndMarkets.com

March 19, 2019

DUBLIN--(BUSINESS WIRE)--Mar 19, 2019--The “Infectious Wound Care Management Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.

The infectious wound care management market is expected to register a CAGR of nearly 2.8% during the forecast period, 2019-2024.

The growth of the market studied can be attributed to the increasing global geriatric population. As the population is increasing, age-related diseases are on the rise, thereby bolstering the demand for wound care management products.

The current market is also growing due to the increasing prevalence of diabetes and rise in number of the accidents and burns. These factors are fueling the growth of the market studied. Due to the product innovations in the recent years, the market studied has been growing profitably worldwide.

Key Market Trends

Diabetes Mellitus Segment Expected to Exhibit the Fastest Growth Rate Over the Forecast Period

Diabetic wounds are of three types: neuropathic, ischemic, and neuroischemic. Knowing the distinct features of each wound category is essential for identifying wound progression, infection, and healing. Failure in properly identifying the type of wound can lead to an ineffective diabetic wound treatment plan, causing long-term complications or amputation.

Infections are the main concern in any diabetic wound treatment plan. Due to the high morbidity and mortality rates associated with diabetic wounds, more aggressive forms of infection control are necessary. Both oral and topical antibiotics are recommended for all diabetic wound treatment patients who indicate signs of infection. A diabetes wound patient must be treated holistically, to reduce the risk factors that cause wounds. Achieving control over diabetes is difficult but essential, especially in terms of blood glucose levels, proper nutrition, high blood pressure, and smoking cessation.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall Infectious wound care management market, with the United States accounting for the major contribution to the same. The US segment of the market studied is the most progressive and lucrative in the world, with unconventional practices, products, and world-class clinicians.

According to the National Institutes of Health, human skin wound is a significant indirect threat to the US economy, as the government takes responsibility for the treatment of the public. This has prompted the government to invest significant amounts of money toward developing effective treatment methods. Research in the United States has revealed that the incidence of non-healing cutaneous wounds is about USD 5-7 million per year, in the country. The relative expenditure for these wounds is about USD 25 billion.

Competitive Landscape

Competition among the existing players is high and price pressure has been increasing among the vendors. Despite the high number of market participants, the majority of the market share is controlled by a handful of participants.

The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as Bristol-Myers Squibb Company, Cardinal Health, Sanofi, Smith & Nephew, and 3M, among others.

Topics Covered

1 Introduction

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Dynamics

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of Diabetes

4.2.2 Rising Aging Population

4.2.3 Increasing Number of Accidents and Burn Cases

4.3 Market Restraints

4.3.1 Risks Associated with Improper Usage and Application of Wound Care Products

4.3.2 Side Effects of Antibiotics

4.4 Porter’s Five Forces Analysis

5 Market Segmentation

5.1 Product Type

5.1.1 Therapy Antibiotic Therapy Iodine Therapy Silver Therapy Other Therapies

5.1.2 Device Wound Dressing Film Dressing Silver Dressing Alginate Dressing Other Devices Compression Bandage Negative Pressure Wound Therapy

5.2 Type of Wound

5.2.1 Diabetes Mellitus

5.2.2 Autoimmune Disorder

5.2.3 Hypoxia/Poor Tissue Perfusion

5.2.4 Other Types of Wound

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle East & Africa

5.3.5 South America

6 Competitive Landscape

6.1 Company Profiles

6.1.1 Bristol-Myers Squibb Company

6.1.2 Cardinal Health Inc.

6.1.3 Sanofi

6.1.4 Smith & Nephew

6.1.5 Molnlycke Health Care AB

6.1.6 3M

6.1.7 Kinetics Concept Company

6.1.8 Coloplast Group

6.1.9 Convatec Group PLC

7 Market Opportunities and Future Trends

For more information about this report visit https://www.researchandmarkets.com/research/flf7cc/global_infectious?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190319005551/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Wound Care



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/19/2019 09:38 AM/DISC: 03/19/2019 09:38 AM